[{"Assets_0_Q2_USD":54777766.0,"CommonStockSharesOutstanding_0_Q2_shares":34330441.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-18181000.0,"NetIncomeLoss_2_Q2_USD":-24402590.0,"NetIncomeLoss_1_Q2_USD":-13762214.0,"StockholdersEquity_0_Q2_USD":24282945.0,"Ticker":"AXSM","CIK":"1579428","name":"AXSOME THERAPEUTICS, INC.","OfficialName":"Axsome Therapeutics Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1574461367.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190808"}]